GNI Group Ltd. (2160.T)
JPY 1828.0
(0.66%)
JPY 1828.0
(0.66%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 169.50 JPY | 1026.74% |
| 2022 | -18.29 JPY | -1650.0% |
| 2021 | 1.18 JPY | -95.93% |
| 2020 | 28.96 JPY | 94.23% |
| 2019 | 14.91 JPY | 214.56% |
| 2018 | 4.74 JPY | 201.72% |
| 2017 | -4.66 JPY | 69.0% |
| 2016 | -15.03 JPY | 17.82% |
| 2015 | -18.29 JPY | -88.36% |
| 2014 | -9.71 JPY | 59.29% |
| 2013 | -23.85 JPY | -47.68% |
| 2012 | -16.15 JPY | -0.5% |
| 2011 | -16.07 JPY | -67.22% |
| 2010 | -9.61 JPY | 0.0% |
| 2008 | -62.52 JPY | 2.19% |
| 2007 | -63.92 JPY | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -22.49 JPY | -177.1% |
| 2024 Q1 | 29.17 JPY | -75.92% |
| 2023 Q2 | 34.99 JPY | 585.97% |
| 2023 Q3 | 11.68 JPY | -66.62% |
| 2023 FY | - JPY | 1026.74% |
| 2023 Q1 | -7.20 JPY | 71.34% |
| 2023 Q4 | 121.16 JPY | 937.33% |
| 2022 Q1 | 1.52 JPY | 108.7% |
| 2022 Q3 | 2.66 JPY | 0.38% |
| 2022 Q4 | -25.12 JPY | -1044.36% |
| 2022 FY | - JPY | -1650.0% |
| 2022 Q2 | 2.65 JPY | 74.34% |
| 2021 Q3 | 7.44 JPY | -30.98% |
| 2021 Q1 | 9.50 JPY | -11.96% |
| 2021 Q2 | 10.78 JPY | 13.47% |
| 2021 FY | - JPY | -95.93% |
| 2021 Q4 | -17.47 JPY | -334.81% |
| 2020 Q1 | 3.05 JPY | 231.47% |
| 2020 Q2 | 2.58 JPY | -15.41% |
| 2020 Q3 | 5.12 JPY | 98.45% |
| 2020 Q4 | 10.79 JPY | 110.74% |
| 2020 FY | - JPY | 94.23% |
| 2019 Q3 | 2.39 JPY | 67.13% |
| 2019 Q1 | 2.87 JPY | 187.77% |
| 2019 FY | - JPY | 214.56% |
| 2019 Q2 | 1.43 JPY | -50.17% |
| 2019 Q4 | -2.32 JPY | -197.07% |
| 2018 Q2 | 4.04 JPY | 148.1% |
| 2018 Q3 | 2.67 JPY | -33.91% |
| 2018 Q1 | -8.40 JPY | -239.3% |
| 2018 FY | - JPY | 201.72% |
| 2018 Q4 | -3.27 JPY | -222.47% |
| 2017 Q1 | -5.17 JPY | -191.83% |
| 2017 FY | - JPY | 69.0% |
| 2017 Q3 | -1.68 JPY | -34.4% |
| 2017 Q2 | -1.25 JPY | 75.82% |
| 2017 Q4 | 6.03 JPY | 458.93% |
| 2016 Q1 | -8.34 JPY | -85.75% |
| 2016 Q2 | -9.93 JPY | -19.06% |
| 2016 FY | - JPY | 17.82% |
| 2016 Q4 | 5.63 JPY | 334.58% |
| 2016 Q3 | -2.40 JPY | 75.83% |
| 2015 FY | - JPY | -88.36% |
| 2015 Q2 | -3.87 JPY | 15.5% |
| 2015 Q1 | -4.58 JPY | -248.22% |
| 2015 Q4 | -4.49 JPY | 13.32% |
| 2015 Q3 | -5.18 JPY | -33.85% |
| 2014 Q3 | -2.96 JPY | 17.32% |
| 2014 FY | - JPY | 59.29% |
| 2014 Q4 | 3.09 JPY | 204.39% |
| 2014 Q1 | -4.08 JPY | 19.37% |
| 2014 Q2 | -3.58 JPY | 12.25% |
| 2013 FY | - JPY | -47.68% |
| 2013 Q4 | -5.06 JPY | 52.71% |
| 2013 Q1 | -3.28 JPY | 33.6% |
| 2013 Q2 | -3.40 JPY | -3.66% |
| 2013 Q3 | -10.70 JPY | -214.71% |
| 2012 Q1 | -4.20 JPY | 11.58% |
| 2012 Q4 | -4.94 JPY | -30.34% |
| 2012 Q3 | -3.79 JPY | -16.98% |
| 2012 FY | - JPY | -0.5% |
| 2012 Q2 | -3.24 JPY | 22.86% |
| 2011 Q1 | -4.62 JPY | -2617.65% |
| 2011 Q3 | -3.22 JPY | 8.52% |
| 2011 FY | - JPY | -67.22% |
| 2011 Q4 | -4.75 JPY | -47.52% |
| 2011 Q2 | -3.52 JPY | 23.81% |
| 2010 Q1 | -5.14 JPY | 0.0% |
| 2010 FY | - JPY | 0.0% |
| 2010 Q4 | -0.17 JPY | 15.0% |
| 2010 Q3 | -0.20 JPY | 95.17% |
| 2010 Q2 | -4.14 JPY | 19.46% |
| 2009 Q3 | -6.76 JPY | 1.31% |
| 2009 Q1 | -7.18 JPY | 52.83% |
| 2009 Q2 | -6.85 JPY | 4.6% |
| 2008 FY | - JPY | 2.19% |
| 2008 Q4 | -15.22 JPY | 25.9% |
| 2008 Q3 | -20.54 JPY | -1.18% |
| 2008 Q2 | -20.30 JPY | 0.0% |
| 2007 FY | - JPY | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 92.20 JPY | -83.839% |
| PRISM BioLab Co.,LTD | -14.90 JPY | 1237.584% |
| Linical Co., Ltd. | 14.98 JPY | -1031.509% |
| Trans Genic Inc. | 0.24 JPY | -70525.0% |
| MEDINET Co., Ltd. | -6.65 JPY | 2648.872% |
| Soiken Holdings Inc. | -25.32 JPY | 769.431% |
| Cytori Cell Research Institute, Inc. | 15.47 JPY | -995.669% |
| AnGes, Inc. | -39.29 JPY | 531.407% |
| OncoTherapy Science, Inc. | -6.05 JPY | 2901.653% |
| Nxera Pharma Co., Ltd. | -87.17 JPY | 294.448% |
| Immuno-Biological Laboratories Co., Ltd. | 20.05 JPY | -745.387% |
| NanoCarrier Co., Ltd. | -11.10 JPY | 1627.027% |
| Carna Biosciences, Inc. | -68.62 JPY | 347.013% |
| CanBas Co., Ltd. | -67.87 JPY | 349.742% |
| D. Western Therapeutics Institute, Inc. | -25.56 JPY | 763.146% |
| RaQualia Pharma Inc. | -14.98 JPY | 1231.509% |
| Chiome Bioscience Inc. | -24.62 JPY | 788.465% |
| Kidswell Bio Corporation | -40.23 JPY | 521.327% |
| PeptiDream Inc. | 23.41 JPY | -624.05% |
| Oncolys BioPharma Inc. | -108.92 JPY | 255.619% |
| Ribomic Inc. | -28.70 JPY | 690.592% |
| SanBio Company Limited | -40.48 JPY | 518.725% |
| Healios K.K. | -56.22 JPY | 401.494% |
| BrightPath Biotherapeutics Co., Ltd. | -18.21 JPY | 1030.807% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -26.79 JPY | 732.699% |
| Delta-Fly Pharma, Inc. | -198.72 JPY | 185.296% |
| StemRIM | -32.98 JPY | 613.948% |
| CellSource Co., Ltd. | 48.88 JPY | -246.768% |
| FunPep Company Limited | -39.63 JPY | 527.706% |
| Kringle Pharma, Inc. | -158.46 JPY | 206.967% |
| Stella Pharma Corporation | -24.66 JPY | 787.348% |
| TMS Co., Ltd. | -26.02 JPY | 751.422% |
| Noile-Immune Biotech Inc. | -27.25 JPY | 722.018% |
| Cuorips Inc. | -85.87 JPY | 297.391% |
| K Pharma,Inc. | 22.43 JPY | -655.684% |
| Takara Bio Inc. | 12.29 JPY | -1279.17% |
| ReproCELL Incorporated | -0.37 JPY | 45910.811% |
| PhoenixBio Co., Ltd. | 6.88 JPY | -2363.663% |
| StemCell Institute Inc. | 30.25 JPY | -460.331% |
| Japan Tissue Engineering Co., Ltd. | 3.53 JPY | -4701.7% |
| CellSeed Inc. | -29.43 JPY | 675.943% |